Amedica (AMDA) Reports Q3 Loss of $0.30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Amedica Corporation Reports Third Quarter 2016 Financial Results
November 10, 2016 5:31 PM ESTSALT LAKE CITY, UT -- (Marketwired) -- 11/10/16 -- Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced financial results for the third quarter ended September 30, 2016.
Recent Company Highlights
Decreased year-to-date operational cash burn by 25% Received FDA clearance for Valeo II Lateral Lumbar interbody fusion device Submitted 510(k) to FDA for new Taurus metals system with first implantation expected by end of the year The first stage of testing of silicon nitride by the... More